Cargando…
Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma
[(18)F]FDG PET/MRI was shown to have limited sensitivity for N-staging in FIGO I/II cervical carcinoma. Therefore, this prospective study aimed to investigate the additional value of multiparametric dual-time-point PET/MRI and to assess potential influencing factors for lymph node metastasis (LNM) d...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456388/ https://www.ncbi.nlm.nih.gov/pubmed/36078873 http://dx.doi.org/10.3390/jcm11174943 |
_version_ | 1784785803390484480 |
---|---|
author | Weissinger, Matthias Kommoss, Stefan Jacoby, Johann Ursprung, Stephan Seith, Ferdinand Hoffmann, Sascha Nikolaou, Konstantin Brucker, Sara Yvonne La Fougère, Christian Dittmann, Helmut |
author_facet | Weissinger, Matthias Kommoss, Stefan Jacoby, Johann Ursprung, Stephan Seith, Ferdinand Hoffmann, Sascha Nikolaou, Konstantin Brucker, Sara Yvonne La Fougère, Christian Dittmann, Helmut |
author_sort | Weissinger, Matthias |
collection | PubMed |
description | [(18)F]FDG PET/MRI was shown to have limited sensitivity for N-staging in FIGO I/II cervical carcinoma. Therefore, this prospective study aimed to investigate the additional value of multiparametric dual-time-point PET/MRI and to assess potential influencing factors for lymph node metastasis (LNM) detection. A total of 63 patients underwent whole-body dual-time-point [(18)F]FDG PET/MRI 60 + 90 min p.i., and 251 LN were evaluated visually, quantified multiparametrically, and correlated with histology. Grading of the primary tumor (G2/G3) had a significant impact on visual detection (sens: 8.3%/31%). The best single parameter for LNM detection was SUVavg, however, with a significant loss of discriminatory power in G2 vs. G3 tumors (AUC: 0.673/0.901). The independent predictors SUVavg, ∆SUVpeak, LN sphericity, ADC, and histologic grade were included in the logistic-regression-based malignancy score (MS) for multiparametric analysis. Application of MS enhanced AUCs, especially in G2 tumors (AUC: G2:0.769; G3:0.877) and improved the accuracy for single LNM from 34.5% to 55.5% compared with the best univariate parameter SUVavg. Compared with visual analysis, the use of the malignancy score increased the overall sensitivity from 31.0% to 79.3% (Youden optimum) with a moderate decrease in specificity from 98.3% to 75.6%. These findings indicate that multiparametric evaluation of dual-time-point PET/MRI has the potential to improve accuracy compared with visual interpretation and enables sufficient N-staging also in G2 cervical carcinoma. |
format | Online Article Text |
id | pubmed-9456388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94563882022-09-09 Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma Weissinger, Matthias Kommoss, Stefan Jacoby, Johann Ursprung, Stephan Seith, Ferdinand Hoffmann, Sascha Nikolaou, Konstantin Brucker, Sara Yvonne La Fougère, Christian Dittmann, Helmut J Clin Med Article [(18)F]FDG PET/MRI was shown to have limited sensitivity for N-staging in FIGO I/II cervical carcinoma. Therefore, this prospective study aimed to investigate the additional value of multiparametric dual-time-point PET/MRI and to assess potential influencing factors for lymph node metastasis (LNM) detection. A total of 63 patients underwent whole-body dual-time-point [(18)F]FDG PET/MRI 60 + 90 min p.i., and 251 LN were evaluated visually, quantified multiparametrically, and correlated with histology. Grading of the primary tumor (G2/G3) had a significant impact on visual detection (sens: 8.3%/31%). The best single parameter for LNM detection was SUVavg, however, with a significant loss of discriminatory power in G2 vs. G3 tumors (AUC: 0.673/0.901). The independent predictors SUVavg, ∆SUVpeak, LN sphericity, ADC, and histologic grade were included in the logistic-regression-based malignancy score (MS) for multiparametric analysis. Application of MS enhanced AUCs, especially in G2 tumors (AUC: G2:0.769; G3:0.877) and improved the accuracy for single LNM from 34.5% to 55.5% compared with the best univariate parameter SUVavg. Compared with visual analysis, the use of the malignancy score increased the overall sensitivity from 31.0% to 79.3% (Youden optimum) with a moderate decrease in specificity from 98.3% to 75.6%. These findings indicate that multiparametric evaluation of dual-time-point PET/MRI has the potential to improve accuracy compared with visual interpretation and enables sufficient N-staging also in G2 cervical carcinoma. MDPI 2022-08-23 /pmc/articles/PMC9456388/ /pubmed/36078873 http://dx.doi.org/10.3390/jcm11174943 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Weissinger, Matthias Kommoss, Stefan Jacoby, Johann Ursprung, Stephan Seith, Ferdinand Hoffmann, Sascha Nikolaou, Konstantin Brucker, Sara Yvonne La Fougère, Christian Dittmann, Helmut Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma |
title | Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma |
title_full | Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma |
title_fullStr | Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma |
title_full_unstemmed | Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma |
title_short | Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma |
title_sort | multiparametric dual-time-point [(18)f]fdg pet/mri for lymph node staging in patients with untreated figo i/ii cervical carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456388/ https://www.ncbi.nlm.nih.gov/pubmed/36078873 http://dx.doi.org/10.3390/jcm11174943 |
work_keys_str_mv | AT weissingermatthias multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT kommossstefan multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT jacobyjohann multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT ursprungstephan multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT seithferdinand multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT hoffmannsascha multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT nikolaoukonstantin multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT bruckersarayvonne multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT lafougerechristian multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma AT dittmannhelmut multiparametricdualtimepoint18ffdgpetmriforlymphnodestaginginpatientswithuntreatedfigoiiicervicalcarcinoma |